Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Arrhythmias

  Free Subscription


Articles published in Stroke

Retrieve available abstracts of 190 articles:
HTML format



Single Articles


    July 2021
  1. REDDIN C, Judge C, Loughlin E, Murphy R, et al
    Association of Oral Anticoagulation With Stroke in Atrial Fibrillation or Heart Failure: A Comparative Meta-Analysis.
    Stroke. 2021 Jul 20:STROKEAHA120033910. doi: 10.1161/STROKEAHA.120.033910.
    PubMed     Abstract available


  2. GRIMALDI-BENSOUDA L, Le Heuzey JY, Ferrieres J, Leys D, et al
    Stroke Prevention by Anticoagulants in Daily Practice Depending on Atrial Fibrillation Pattern and Clinical Risk Factors.
    Stroke. 2021 Jul 13:STROKEAHA120032704. doi: 10.1161/STROKEAHA.120.032704.
    PubMed     Abstract available


  3. CHAN YH, Chao TF, Lee HF, Chen SW, et al
    Clinical Outcomes in Atrial Fibrillation Patients With a History of Cancer Treated With Non-Vitamin K Antagonist Oral Anticoagulants: A Nationwide Cohort Study.
    Stroke. 2021 Jul 8:STROKEAHA120033470. doi: 10.1161/STROKEAHA.120.033470.
    PubMed     Abstract available


    June 2021
  4. DING M, Wang R, Kalpouzos G, Laukka EJ, et al
    Cerebral Small Vessel Disease Associated With Atrial Fibrillation Among Older Adults: A Population-Based Study.
    Stroke. 2021 Jun 17:STROKEAHA120031573. doi: 10.1161/STROKEAHA.120.031573.
    PubMed     Abstract available


  5. MAC GRORY B, Landman SR, Ziegler PD, Boisvert CJ, et al
    Detection of Atrial Fibrillation After Central Retinal Artery Occlusion.
    Stroke. 2021 Jun 7:STROKEAHA120033934. doi: 10.1161/STROKEAHA.120.033934.
    PubMed     Abstract available


    April 2021
  6. DALMAR A, Singh M, Heis Z, Cumpian TL, et al
    Risk of Atrial Fibrillation and Stroke After Bariatric Surgery in Patients With Morbid Obesity With or Without Obstructive Sleep Apnea.
    Stroke. 2021 Apr 21:STROKEAHA120031920. doi: 10.1161/STROKEAHA.120.031920.
    PubMed     Abstract available


  7. ZHOU Z, Jardine MJ, Li Q, Neuen BL, et al
    Effect of SGLT2 Inhibitors on Stroke and Atrial Fibrillation in Diabetic Kidney Disease: Results From the CREDENCE Trial and Meta-Analysis.
    Stroke. 2021 Apr 20:STROKEAHA120031623. doi: 10.1161/STROKEAHA.120.031623.
    PubMed     Abstract available


  8. GABET A, Guenancia C, Duloquin G, Olie V, et al
    Ischemic Stroke With Atrial Fibrillation: Characteristics and Time Trends 2006 to 2017 in the Dijon Stroke Registry.
    Stroke. 2021 Apr 20:STROKEAHA120030812. doi: 10.1161/STROKEAHA.120.030812.
    PubMed     Abstract available


  9. PARK JH, Chung JW, Bang OY, Kim GM, et al
    Atherosclerotic Burden and Vascular Risk in Stroke Patients With Atrial Fibrillation.
    Stroke. 2021 Apr 2:STROKEAHA120032232. doi: 10.1161/STROKEAHA.120.032232.
    PubMed     Abstract available


    March 2021
  10. STRAMBO D, Sirimarco G, Nannoni S, Perlepe K, et al
    Embolic Stroke of Undetermined Source and Patent Foramen Ovale: Risk of Paradoxical Embolism Score Validation and Atrial Fibrillation Prediction.
    Stroke. 2021 Mar 31:STROKEAHA120032453. doi: 10.1161/STROKEAHA.120.032453.
    PubMed     Abstract available


  11. PACIARONI M, Agnelli G, Giustozzi M, Caso V, et al
    Risk Factors for Intracerebral Hemorrhage in Patients With Atrial Fibrillation on Non-Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention.
    Stroke. 2021 Mar 4:STROKEAHA120031827. doi: 10.1161/STROKEAHA.120.031827.
    PubMed     Abstract available


    February 2021
  12. DE MARCHIS GM, Sposato LA, Kuhne M, Dittrich TD, et al
    New Avenues for Optimal Treatment of Atrial Fibrillation and Stroke Prevention.
    Stroke. 2021 Feb 25:STROKEAHA120032060. doi: 10.1161/STROKEAHA.120.032060.
    PubMed     Abstract available


  13. LABOVITZ AJ, Rose DZ, Fradley MG, Meriwether JN, et al
    Early Apixaban Use Following Stroke in Patients With Atrial Fibrillation: Results of the AREST Trial.
    Stroke. 2021 Feb 25:STROKEAHA120030042. doi: 10.1161/STROKEAHA.120.030042.
    PubMed     Abstract available


  14. CHEN JZ, Thijs VN
    Atrial Fibrillation Following Patent Foramen Ovale Closure: Systematic Review and Meta-Analysis of Observational Studies and Clinical Trials.
    Stroke. 2021 Feb 22:STROKEAHA120030293. doi: 10.1161/STROKEAHA.120.030293.
    PubMed     Abstract available


  15. ZHU W, Ye Z, Chen S, Wu D, et al
    Comparative Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients.
    Stroke. 2021 Feb 18:STROKEAHA120031007. doi: 10.1161/STROKEAHA.120.031007.
    PubMed     Abstract available


  16. PARK YJ, Kim JS, Park KM, On YK, et al
    Subclinical Atrial Fibrillation Burden and Adverse Clinical Outcomes in Patients With Permanent Pacemakers.
    Stroke. 2021 Feb 16:STROKEAHA120031822. doi: 10.1161/STROKEAHA.120.031822.
    PubMed     Abstract available


  17. QURESHI AI, Baskett WI, Huang W, Shyu D, et al
    Acute Ischemic Stroke and COVID-19: An Analysis of 27 676 Patients.
    Stroke. 2021 Feb 4:STROKEAHA120031786. doi: 10.1161/STROKEAHA.120.031786.
    PubMed     Abstract available


    January 2021
  18. HART RG
    Atrial Fibrillation and Prevention of Embolic Stroke: Personal Reflections.
    Stroke. 2021 Jan 11:STROKEAHA120030420. doi: 10.1161/STROKEAHA.120.030420.
    PubMed    


  19. LEE SR, Choi EK, Jung JH, Park SH, et al
    Body Mass Index and Clinical Outcomes in Asian Patients With Atrial Fibrillation Receiving Oral Anticoagulation.
    Stroke. 2021 Jan 11:STROKEAHA120030356. doi: 10.1161/STROKEAHA.120.030356.
    PubMed     Abstract available


  20. KWON S, Lee SR, Choi EK, Lee E, et al
    Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation and Prior Gastrointestinal Bleeding.
    Stroke. 2021 Jan 8:STROKEAHA120030761. doi: 10.1161/STROKEAHA.120.030761.
    PubMed     Abstract available


    December 2020
  21. KOSHY AN, Enyati A, Weinberg L, Han HC, et al
    Postoperative Atrial Fibrillation and Long-Term Risk of Stroke in Patients Undergoing Liver Transplantation.
    Stroke. 2020 Dec 22:STROKEAHA120031454. doi: 10.1161/STROKEAHA.120.031454.
    PubMed     Abstract available


  22. AGUIAR DE SOUSA D, Katan M
    Promising Use of Automated Electronic Phenotyping: Turning Big Data Into Big Value in Stroke Research.
    Stroke. 2020 Dec 10:STROKEAHA120033061. doi: 10.1161/STROKEAHA.120.033061.
    PubMed    


  23. GUAN W, Ko D, Khurshid S, Trisini Lipsanopoulos AT, et al
    Automated Electronic Phenotyping of Cardioembolic Stroke.
    Stroke. 2020 Dec 10:STROKEAHA120030663. doi: 10.1161/STROKEAHA.120.030663.
    PubMed     Abstract available


  24. HUSSEIN HM, Anderson DC
    Small Vessel Disease: Perpetrator or Predictor of Stroke in Patients With Atrial Fibrillation?
    Stroke. 2020 Dec 7:STROKEAHA120032536. doi: 10.1161/STROKEAHA.120.032536.
    PubMed    


  25. DU H, Wilson D, Ambler G, Banerjee G, et al
    Small Vessel Disease and Ischemic Stroke Risk During Anticoagulation for Atrial Fibrillation After Cerebral Ischemia.
    Stroke. 2020 Dec 7:STROKEAHA120029474. doi: 10.1161/STROKEAHA.120.029474.
    PubMed     Abstract available


  26. PENGO MF, Faini A, Grote L, Ludka O, et al
    Impact of Sleep Apnea on Cardioembolic Risk in Patients With Atrial Fibrillation: Data From the ESADA Cohort.
    Stroke. 2020 Dec 4:STROKEAHA120030285. doi: 10.1161/STROKEAHA.120.030285.
    PubMed     Abstract available


  27. WETMORE JB, Roetker NS, Herzog CA
    Response by Wetmore et al to Letter Regarding Article, "Direct-Acting Oral Anticoagulants Versus Warfarin in Medicare Patients With Chronic Kidney Disease and Atrial Fibrillation".
    Stroke. 2020;51:e363-e364.
    PubMed    


  28. DING WY, Rivera-Caravaca JM, Lip GYH
    Letter by Ding et al Regarding Article, "Direct-Acting Oral Anticoagulants Versus Warfarin in Medicare Patients With Chronic Kidney Disease and Atrial Fibrillation".
    Stroke. 2020;51:e361-e362.
    PubMed    


    November 2020
  29. SENADEERA SC, Palmer DG, Keenan R, Beharry J, et al
    Left Atrial Appendage Thrombus Detected During Hyperacute Stroke Imaging Is Associated With Atrial Fibrillation.
    Stroke. 2020 Nov 9:STROKEAHA120030258. doi: 10.1161/STROKEAHA.120.030258.
    PubMed     Abstract available


    October 2020
  30. SPENCE JD, Azarpazhooh MR, Larsson SC, Bogiatzi C, et al
    Stroke Prevention in Older Adults: Recent Advances.
    Stroke. 2020 Oct 30:STROKEAHA120031707. doi: 10.1161/STROKEAHA.120.031707.
    PubMed     Abstract available


  31. GROSSE GM, Sieweke JT, Biber S, Ziegler NL, et al
    Nonstenotic Carotid Plaque in Embolic Stroke of Undetermined Source: Interplay of Arterial and Atrial Disease.
    Stroke. 2020 Oct 12:STROKEAHA120030537. doi: 10.1161/STROKEAHA.120.030537.
    PubMed     Abstract available


  32. HAAS K, Rucker V, Hermanek P, Misselwitz B, et al
    Association Between Adherence to Quality Indicators and 7-Day In-Hospital Mortality After Acute Ischemic Stroke.
    Stroke. 2020 Oct 12:STROKEAHA120029968. doi: 10.1161/STROKEAHA.120.029968.
    PubMed     Abstract available


  33. ZHOU E, Lord A, Boehme A, Henninger N, et al
    Risk of Ischemic Stroke in Patients With Atrial Fibrillation After Extracranial Hemorrhage.
    Stroke. 2020 Oct 8:STROKEAHA120029959. doi: 10.1161/STROKEAHA.120.029959.
    PubMed     Abstract available


  34. CHOI KH, Kim JH, Lee C, Kim JM, et al
    Microbleeds and Outcome in Patients With Acute Ischemic Stroke and Atrial Fibrillation Taking Anticoagulants.
    Stroke. 2020 Oct 8:STROKEAHA120030300. doi: 10.1161/STROKEAHA.120.030300.
    PubMed     Abstract available


    September 2020
  35. ELKIND MSV, Boehme AK, Smith CJ, Meisel A, et al
    Infection as a Stroke Risk Factor and Determinant of Outcome After Stroke.
    Stroke. 2020 Sep 8:STROKEAHA120030429. doi: 10.1161/STROKEAHA.120.030429.
    PubMed     Abstract available



  36. Correction to: Comparative Safety and Effectiveness of Oral Anticoagulants in Nonvalvular Atrial Fibrillation: The NAXOS Study.
    Stroke. 2020;51:e271.
    PubMed    


    August 2020
  37. JUNG YH, Kim YD, Kim J, Han SW, et al
    Initial Stroke Severity in Patients With Atrial Fibrillation According to Antithrombotic Therapy Before Ischemic Stroke.
    Stroke. 2020 Aug 19:STROKEAHA120030138. doi: 10.1161/STROKEAHA.120.030138.
    PubMed     Abstract available


  38. KAMEL H, Navi BB, Parikh NS, Merkler AE, et al
    Machine Learning Prediction of Stroke Mechanism in Embolic Strokes of Undetermined Source.
    Stroke. 2020 Aug 12:STROKEAHA120029305. doi: 10.1161/STROKEAHA.120.029305.
    PubMed     Abstract available


  39. NGUYEN-HUYNH MN, Tang XN, Vinson DR, Flint AC, et al
    Acute Stroke Presentation, Care, and Outcomes in Community Hospitals in Northern California During the COVID-19 Pandemic.
    Stroke. 2020 Aug 7:STROKEAHA120031099. doi: 10.1161/STROKEAHA.120.031099.
    PubMed     Abstract available


  40. SEIFFGE DJ, Goeldlin M
    Art of Anticoagulation After Recent Ischemic Stroke.
    Stroke. 2020 Aug 6:STROKEAHA120030997. doi: 10.1161/STROKEAHA.120.030997.
    PubMed    


  41. YAGHI S, Mistry E, Liberman AL, Giles J, et al
    Anticoagulation Type and Early Recurrence in Cardioembolic Stroke: The IAC Study.
    Stroke. 2020 Aug 6:STROKEAHA120028867. doi: 10.1161/STROKEAHA.120.028867.
    PubMed     Abstract available


    July 2020
  42. GIUSTOZZI M, Acciarresi M, Agnelli G, Caso V, et al
    Safety of Anticoagulation in Patients Treated With Urgent Reperfusion for Ischemic Stroke Related to Atrial Fibrillation.
    Stroke. 2020 Jul 10:STROKEAHA120030143. doi: 10.1161/STROKEAHA.120.030143.
    PubMed     Abstract available


  43. WETMORE JB, Roetker NS, Yan H, Reyes JL, et al
    Direct-Acting Oral Anticoagulants Versus Warfarin in Medicare Patients With Chronic Kidney Disease and Atrial Fibrillation.
    Stroke. 2020 Jul 9:STROKEAHA120028934. doi: 10.1161/STROKEAHA.120.028934.
    PubMed     Abstract available


  44. ONG E, Meseguer E, Guidoux C, Lavallee PC, et al
    Prevalence and Outcome of Potential Candidates for Left Atrial Appendage Closure After Stroke With Atrial Fibrillation: WATCH-AF Registry.
    Stroke. 2020 Jul 9:STROKEAHA120029267. doi: 10.1161/STROKEAHA.120.029267.
    PubMed     Abstract available


    June 2020
  45. TANAKA K, Koga M, Bae HJ
    Response by Tanaka et al to Letter Regarding Article, "Atrial Fibrillation-Associated Ischemic Stroke Patients With Prior Anticoagulation Have Higher Risk for Recurrent Stroke".
    Stroke. 2020 Jun 26:STROKEAHA120030414. doi: 10.1161/STROKEAHA.120.030414.
    PubMed    


  46. HSIEH CY, Sung SF
    Letter by Hsieh and Sung Regarding Article, "Atrial Fibrillation-Associated Ischemic Stroke Patients With Prior Anticoagulation Have Higher Risk for Recurrent Stroke".
    Stroke. 2020 Jun 26:STROKEAHA120030101. doi: 10.1161/STROKEAHA.120.030101.
    PubMed    


  47. VAN GANSE E, Danchin N, Mahe I, Hanon O, et al
    Comparative Safety and Effectiveness of Oral Anticoagulants in Nonvalvular Atrial Fibrillation: The NAXOS Study.
    Stroke. 2020 Jun 16:STROKEAHA120028825. doi: 10.1161/STROKEAHA.120.028825.
    PubMed     Abstract available


  48. MENTIAS A, Heller E, Vaughan Sarrazin M
    Comparative Effectiveness of Rivaroxaban, Apixaban, and Warfarin in Atrial Fibrillation Patients With Polypharmacy.
    Stroke. 2020 Jun 10:STROKEAHA120029541. doi: 10.1161/STROKEAHA.120.029541.
    PubMed     Abstract available


  49. CHEW DS, Rennert-May E, Spackman E, Mark DB, et al
    Cost-Effectiveness of Extended Electrocardiogram Monitoring for Atrial Fibrillation After Stroke: A Systematic Review.
    Stroke. 2020 Jun 5:STROKEAHA120029340. doi: 10.1161/STROKEAHA.120.029340.
    PubMed     Abstract available


    May 2020
  50. KRITTAYAPHONG R, Winijkul A, Kunjara-Na-Ayudhya R, Apiyasawat S, et al
    Adherence to Anticoagulant Guideline for Atrial Fibrillation Improves Outcomes in Asian Population: The COOL-AF Registry.
    Stroke. 2020 May 11:STROKEAHA120029295. doi: 10.1161/STROKEAHA.120.029295.
    PubMed     Abstract available


  51. BODIN A, Bisson A, Gaborit C, Herbert J, et al
    Ischemic Stroke in Patients With Sinus Node Disease, Atrial Fibrillation, and Other Cardiac Conditions.
    Stroke. 2020 May 11:STROKEAHA120029048. doi: 10.1161/STROKEAHA.120.029048.
    PubMed     Abstract available



  52. Correction to: Ischemic Stroke and Bleeding: Clinical Benefit of Anticoagulation in Atrial Fibrillation After Intracerebral Hemorrhage.
    Stroke. 2020;51:e100.
    PubMed    



  53. Correction to: Atrial Fibrillation-Associated Ischemic Stroke Patients With Prior Anticoagulation Have Higher Risk for Recurrent Stroke.
    Stroke. 2020;51:e99.
    PubMed    


  54. MURTHY SB, Wu X, Diaz I, Parasram M, et al
    Non-Traumatic Subdural Hemorrhage and Risk of Arterial Ischemic Events.
    Stroke. 2020;51:1464-1469.
    PubMed     Abstract available


    April 2020
  55. LEE SR, Choi EK, Lip GYH
    Response by Lee et al to Letter Regarding Article, "Oral Anticoagulation in Asian Patients With Atrial Fibrillation and a History of Intracranial Hemorrhage".
    Stroke. 2020 Apr 27:STROKEAHA120029551. doi: 10.1161/STROKEAHA.120.029551.
    PubMed    


  56. LIANG B, Zhao YX, Gu N
    Letter by Liang et al Regarding Article, "Oral Anticoagulation in Asian Patients With Atrial Fibrillation and a History of Intracranial Hemorrhage".
    Stroke. 2020 Apr 27:STROKEAHA120029434. doi: 10.1161/STROKEAHA.120.029434.
    PubMed    


  57. KOKKINIDIS DG, Zareifopoulos N, Theochari CA, Arfaras-Melainis A, et al
    Association Between Atrial Fibrillation and Cognitive Impairment in Individuals With Prior Stroke: A Meta-Analysis and Meta-Regression Analysis.
    Stroke. 2020 Apr 21:STROKEAHA119027815. doi: 10.1161/STROKEAHA.119.027815.
    PubMed     Abstract available


  58. MCMAHON NE, Bangee M, Benedetto V, Bray EP, et al
    Etiologic Workup in Cases of Cryptogenic Stroke: A Systematic Review of International Clinical Practice Guidelines.
    Stroke. 2020 Apr 13:STROKEAHA119027123. doi: 10.1161/STROKEAHA.119.027123.
    PubMed     Abstract available


  59. KHURSHID S, Trinquart L, Weng LC, Hulme OL, et al
    Atrial Fibrillation Risk and Discrimination of Cardioembolic From Noncardioembolic Stroke.
    Stroke. 2020 Apr 7:STROKEAHA120028837. doi: 10.1161/STROKEAHA.120.028837.
    PubMed     Abstract available



  60. Correction to: Effectiveness and Safety of Oral Anticoagulants Among Nonvalvular Atrial Fibrillation Patients: The ARISTOPHANES Study.
    Stroke. 2020;51:e71.
    PubMed    


    March 2020
  61. ANDREASEN C, Gislason GH, Kober L, Abdulla J, et al
    Incidence of Ischemic Stroke in Individuals With and Without Aortic Valve Stenosis: A Danish Retrospective Cohort Study.
    Stroke. 2020 Mar 27:STROKEAHA119028389. doi: 10.1161/STROKEAHA.119.028389.
    PubMed     Abstract available


  62. BEHARRY J, Waters MJ, Drew R, Fink JN, et al
    Dabigatran Reversal Before Intravenous Tenecteplase in Acute Ischemic Stroke.
    Stroke. 2020 Mar 25:STROKEAHA119028327. doi: 10.1161/STROKEAHA.119.028327.
    PubMed     Abstract available


    February 2020
  63. TANAKA K, Koga M, Lee KJ, Kim BJ, et al
    Atrial Fibrillation-Associated Ischemic Stroke Patients With Prior Anticoagulation Have Higher Risk for Recurrent Stroke.
    Stroke. 2020 Feb 26:STROKEAHA119027275. doi: 10.1161/STROKEAHA.119.027275.
    PubMed     Abstract available


  64. CAO S, Wang J, Xia M
    Letter by Cao et al Regarding Article, "Prevalence of Microembolic Signals in Embolic Stroke of Undetermined Source and Other Subtypes of Ischemic Stroke".
    Stroke. 2020 Feb 26:STROKEAHA119028801. doi: 10.1161/STROKEAHA.119.028801.
    PubMed    


    January 2020
  65. STANTON RJ, Eckman MH, Woo D, Moomaw CJ, et al
    Ischemic Stroke and Bleeding: Clinical Benefit of Anticoagulation in Atrial Fibrillation After Intracerebral Hemorrhage.
    Stroke. 2020 Jan 31:STROKEAHA119027370. doi: 10.1161/STROKEAHA.119.027370.
    PubMed     Abstract available


  66. YE K, Chen W
    Letter by Ye and Chen Regarding Article, "Metabolic Syndrome and Risk of Ischemic Stroke in Atrial Fibrillation: ARIC Study".
    Stroke. 2020 Jan 29:STROKEAHA119028635. doi: 10.1161/STROKEAHA.119.028635.
    PubMed    


  67. MIZOGUCHI T, Tanaka K, Toyoda K, Yoshimura S, et al
    Early Initiation of Direct Oral Anticoagulants After Onset of Stroke and Short- and Long-Term Outcomes of Patients With Nonvalvular Atrial Fibrillation.
    Stroke. 2020 Jan 22:STROKEAHA119028118. doi: 10.1161/STROKEAHA.119.028118.
    PubMed     Abstract available



  68. Correction to: Effectiveness and Safety of Oral Anticoagulants Among Nonvalvular Atrial Fibrillation Patients: The ARISTOPHANES Study.
    Stroke. 2020 Jan 10:STR0000000000000218. doi: 10.1161/STR.0000000000000218.
    PubMed    


  69. GOMIS M, Davalos A, Purroy F, Cardona P, et al
    Stroke Risk Analysis, a System With a High Detection Rate of Atrial Fibrillation in Stroke and Transient Ischemic Attack.
    Stroke. 2020;51:262-267.
    PubMed     Abstract available


  70. OLIVIERI O, Cappellari M, Turcato G, Bonetti B, et al
    Increased Incidence of Ischemic Cerebrovascular Events in Cardiovascular Patients With Elevated Apolipoprotein CIII.
    Stroke. 2020;51:61-68.
    PubMed     Abstract available


  71. MURTHY SB, Diaz I, Wu X, Merkler AE, et al
    Risk of Arterial Ischemic Events After Intracerebral Hemorrhage.
    Stroke. 2020;51:137-142.
    PubMed     Abstract available


  72. GUTIERREZ J, Gil-Guevara A, Ramaswamy S, DeRosa J, et al
    Classification of Covert Brain Infarct Subtype and Risk of Death and Vascular Events.
    Stroke. 2020;51:90-98.
    PubMed     Abstract available


    December 2019
  73. ALBERTS M, Chen YW, Lin JH, Kogan E, et al
    Risks of Stroke and Mortality in Atrial Fibrillation Patients Treated With Rivaroxaban and Warfarin.
    Stroke. 2019 Dec 31:STROKEAHA119025554. doi: 10.1161/STROKEAHA.119.025554.
    PubMed     Abstract available


  74. SHAHJOUEI S, Tsivgoulis G, Goyal N, Sadighi A, et al
    Safety of Intravenous Thrombolysis Among Patients Taking Direct Oral Anticoagulants: A Systematic Review and Meta-Analysis.
    Stroke. 2019 Dec 30:STROKEAHA119026426. doi: 10.1161/STROKEAHA.119.026426.
    PubMed     Abstract available


  75. NTAIOS G, Perlepe K, Lambrou D, Sirimarco G, et al
    External Performance of the HAVOC Score for the Prediction of New Incident Atrial Fibrillation.
    Stroke. 2019 Dec 12:STROKEAHA119027990. doi: 10.1161/STROKEAHA.119.027990.
    PubMed     Abstract available


  76. LEE SR, Choi EK, Kwon S, Jung JH, et al
    Oral Anticoagulation in Asian Patients With Atrial Fibrillation and a History of Intracranial Hemorrhage.
    Stroke. 2019 Dec 9:STROKEAHA119028030. doi: 10.1161/STROKEAHA.119.028030.
    PubMed     Abstract available


  77. WASSER K, Weber-Kruger M, Groschel S, Uphaus T, et al
    Brain Natriuretic Peptide and Discovery of Atrial Fibrillation After Stroke: A Subanalysis of the Find-AFRANDOMISED Trial.
    Stroke. 2019 Dec 9:STROKEAHA119026496. doi: 10.1161/STROKEAHA.119.026496.
    PubMed     Abstract available


  78. CHENG WH, Chao TF
    Response by Cheng and Chao to Letter Regarding Article, "Low-Dose Rivaroxaban and Risks of Adverse Events in Patients With Atrial Fibrillation".
    Stroke. 2019 Dec 4:STROKEAHA119027909. doi: 10.1161/STROKEAHA.119.027909.
    PubMed    


  79. LEE KJ, Kim BJ, Han MK, Kim JT, et al
    Effect of Heart Rate on Stroke Recurrence and Mortality in Acute Ischemic Stroke With Atrial Fibrillation.
    Stroke. 2019 Dec 4:STROKEAHA119026847. doi: 10.1161/STROKEAHA.119.026847.
    PubMed     Abstract available


  80. XIANG Q, Cui Y
    Letter by Xiang and Cui Regarding Article, "Low-Dose Rivaroxaban and Risks of Adverse Events in Patients With Atrial Fibrillation".
    Stroke. 2019 Dec 4:STROKEAHA119027857. doi: 10.1161/STROKEAHA.119.027857.
    PubMed    



  81. Correction to: Atrial Fibrillation Ablation and Reduction of Stroke Events: Understanding the Paradoxical Lack of Evidence.
    Stroke. 2019;50:e438.
    PubMed    


    October 2019
  82. DECKER JJ, Norby FL, Rooney MR, Soliman EZ, et al
    Metabolic Syndrome and Risk of Ischemic Stroke in Atrial Fibrillation: ARIC Study.
    Stroke. 2019 Oct 18:STROKEAHA119025376. doi: 10.1161/STROKEAHA.119.025376.
    PubMed     Abstract available


    September 2019
  83. HO JSY, Tan BYQ, Sia CH
    Letter by Ho et al Regarding Article, "Left Atrial Volume Index Is Associated With Cardioembolic Stroke and Atrial Fibrillation Detection After Embolic Stroke of Undetermined Source".
    Stroke. 2019 Sep 20:STROKEAHA119027179. doi: 10.1161/STROKEAHA.119.027179.
    PubMed    


  84. JORDAN K, Yaghi S, Song C
    Response by Jordan et al to Letter Regarding Article, "Left Atrial Volume Index Is Associated With Cardioembolic Stroke and Atrial Fibrillation Detection After Embolic Stroke of Undetermined Source".
    Stroke. 2019 Sep 20:STROKEAHA119027235. doi: 10.1161/STROKEAHA.119.027235.
    PubMed    


  85. LERARIO MP, Grotta JC, Merkler AE, Omran SS, et al
    Association Between Intravenous Thrombolysis and Anaphylaxis Among Medicare Beneficiaries With Acute Ischemic Stroke.
    Stroke. 2019 Sep 13:STROKEAHA119026861. doi: 10.1161/STROKEAHA.119.026861.
    PubMed     Abstract available


  86. BARRA S, Narayanan K, Boveda S, Primo J, et al
    Atrial Fibrillation Ablation and Reduction of Stroke Events: Understanding the Paradoxical Lack of Evidence.
    Stroke. 2019 Sep 12:STROKEAHA119026890. doi: 10.1161/STROKEAHA.119.026890.
    PubMed    


  87. MANWANI B, McCullough LD
    On the Basis of Sex.
    Stroke. 2019;50:2285-2287.
    PubMed    


    August 2019
  88. XUE Z, Zhang H
    Non-Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Asians With Atrial Fibrillation.
    Stroke. 2019 Aug 19:STROKEAHA119026054. doi: 10.1161/STROKEAHA.119.026054.
    PubMed     Abstract available


  89. JORDAN K, Yaghi S, Song C
    Response by Jordan et al to Letter Regarding Article, "Left Atrial Volume Index Is Associated With Cardioembolic Stroke and Atrial Fibrillation Detection After Embolic Stroke of Undetermined Source".
    Stroke. 2019 Aug 14:STROKEAHA119026858. doi: 10.1161/STROKEAHA.119.026858.
    PubMed    


  90. MULLER P, Akoum N, Eckardt L
    Letter by Muller et al Regarding Article, "Left Atrial Volume Index Is Associated With Cardioembolic Stroke and Atrial Fibrillation Detection After Embolic Stroke of Undetermined Source".
    Stroke. 2019 Aug 14:STROKEAHA119026818. doi: 10.1161/STROKEAHA.119.026818.
    PubMed    


  91. BLIN P, Fauchier L, Dureau-Pournin C, Sacher F, et al
    Effectiveness and Safety of Rivaroxaban 15 or 20 mg Versus Vitamin K Antagonists in Nonvalvular Atrial Fibrillation.
    Stroke. 2019 Aug 8:STROKEAHA119025824. doi: 10.1161/STROKEAHA.119.025824.
    PubMed     Abstract available


    July 2019
  92. LEE HJ, Kim HK, Jung JH, Han KD, et al
    Novel Oral Anticoagulants for Primary Stroke Prevention in Hypertrophic Cardiomyopathy Patients With Atrial Fibrillation.
    Stroke. 2019 Jul 25:STROKEAHA119026048. doi: 10.1161/STROKEAHA.119.026048.
    PubMed     Abstract available


  93. ZHU X, Cao S, Ding C
    Letter by Zhu et al Regarding Article, "Atrial Fibrillation Known Before or Detected After Stroke Share Similar Risk of Ischemic Stroke Recurrence and Death".
    Stroke. 2019 Jul 25:STROKEAHA119026368. doi: 10.1161/STROKEAHA.119.026368.
    PubMed    


  94. YANG XM, Li ZX, Wang YJ
    Response by Yang et al to Letter Regarding Article, "Atrial Fibrillation Known Before or Detected After Stroke Share Similar Risk of Ischemic Stroke Recurrence and Death".
    Stroke. 2019 Jul 25:STROKEAHA119026551. doi: 10.1161/STROKEAHA.119.026551.
    PubMed    


  95. MCALISTER FA, Yan L, Roos LL, Lix LM, et al
    Parental Atrial Fibrillation and Stroke or Atrial Fibrillation in Young Adults.
    Stroke. 2019 Jul 24:STROKEAHA119025124. doi: 10.1161/STROKEAHA.119.025124.
    PubMed     Abstract available


  96. KNIJNIK L, Rivera M, Blumer V, Cardoso R, et al
    Prevention of Stroke in Atrial Fibrillation After Coronary Stenting.
    Stroke. 2019 Jul 15:STROKEAHA119026078. doi: 10.1161/STROKEAHA.119.026078.
    PubMed     Abstract available


  97. CHENG WH, Chao TF, Lin YJ, Chang SL, et al
    Low-Dose Rivaroxaban and Risks of Adverse Events in Patients With Atrial Fibrillation.
    Stroke. 2019 Jul 10:STROKEAHA119025623. doi: 10.1161/STROKEAHA.119.025623.
    PubMed     Abstract available


    June 2019
  98. PACIARONI M, Agnelli G, Caso V, Silvestrelli G, et al
    Causes and Risk Factors of Cerebral Ischemic Events in Patients With Atrial Fibrillation Treated With Non-Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention.
    Stroke. 2019 Jun 25:STROKEAHA119025350. doi: 10.1161/STROKEAHA.119.025350.
    PubMed     Abstract available


  99. ALTAVILLA R, Caso V, Bandini F, Agnelli G, et al
    Anticoagulation After Stroke in Patients With Atrial Fibrillation.
    Stroke. 2019 Jun 21:STROKEAHA118022856. doi: 10.1161/STROKEAHA.118.022856.
    PubMed     Abstract available


  100. CAMPBELL BCV
    More Reasons to Avoid Bridging Anticoagulation After Stroke in Patients With Atrial Fibrillation.
    Stroke. 2019 Jun 21:STROKEAHA119025770. doi: 10.1161/STROKEAHA.119.025770.
    PubMed    


  101. KNEIHSL M, Gattringer T, Bisping E, Scherr D, et al
    Blood Biomarkers of Heart Failure and Hypercoagulation to Identify Atrial Fibrillation-Related Stroke.
    Stroke. 2019 Jun 20:STROKEAHA119025339. doi: 10.1161/STROKEAHA.119.025339.
    PubMed     Abstract available


  102. KOZIEL M, Potpara TS, Lip GYH
    Using Blood Biomarkers to Identify Atrial Fibrillation-Related Stroke.
    Stroke. 2019 Jun 20:STROKEAHA119026185. doi: 10.1161/STROKEAHA.119.026185.
    PubMed    


  103. TSIVGOULIS G, Katsanos AH, Grory BM, Kohrmann M, et al
    Prolonged Cardiac Rhythm Monitoring and Secondary Stroke Prevention in Patients With Cryptogenic Cerebral Ischemia.
    Stroke. 2019 Jun 20:STROKEAHA119025169. doi: 10.1161/STROKEAHA.119.025169.
    PubMed     Abstract available


  104. LEE SR, Choi EK, Kwon S, Han KD, et al
    Effectiveness and Safety of Contemporary Oral Anticoagulants Among Asians With Nonvalvular Atrial Fibrillation.
    Stroke. 2019 Jun 18:STROKEAHA119025536. doi: 10.1161/STROKEAHA.119.025536.
    PubMed     Abstract available


  105. JORDAN K, Yaghi S, Poppas A, Chang AD, et al
    Left Atrial Volume Index Is Associated With Cardioembolic Stroke and Atrial Fibrillation Detection After Embolic Stroke of Undetermined Source.
    Stroke. 2019 Jun 13:STROKEAHA119025384. doi: 10.1161/STROKEAHA.119.025384.
    PubMed     Abstract available


  106. BROWN DL, Xu G, Belinky Krzyske AM, Buhay NC, et al
    Electrocardiomatrix Facilitates Accurate Detection of Atrial Fibrillation in Stroke Patients.
    Stroke. 2019 Jun 10:STROKEAHA119025361. doi: 10.1161/STROKEAHA.119.025361.
    PubMed     Abstract available


  107. PANA TA, McLernon DJ, Mamas MA, Bettencourt-Silva JH, et al
    Individual and Combined Impact of Heart Failure and Atrial Fibrillation on Ischemic Stroke Outcomes.
    Stroke. 2019 Jun 3:STROKEAHA119025481. doi: 10.1161/STROKEAHA.119.025481.
    PubMed     Abstract available


  108. LEE SR, Choi EK, Han KD, Jung JH, et al
    Non-Vitamin K Antagonist Oral Anticoagulants in Asian Patients With Supranormal Renal Function.
    Stroke. 2019;50:1480-1489.
    PubMed     Abstract available


    May 2019
  109. JAYARAMAN DK, Alcusky M, Moonis M
    Letter by Jayaraman et al Regarding Articles, "Higher Incidence of Ischemic Stroke in Patients Taking Novel Oral Anticoagulants" and "Effectiveness and Safety of Oral Anticoagulants among Nonvalvular Atrial Fibrillation Patients: The ARISTOPHANES Stud
    Stroke. 2019 May 16:STROKEAHA119024817. doi: 10.1161/STROKEAHA.119.024817.
    PubMed    


  110. RIVERA-CARAVACA JM, Marin F, Vilchez JA, Galvez J, et al
    Refining Stroke and Bleeding Prediction in Atrial Fibrillation by Adding Consecutive Biomarkers to Clinical Risk Scores.
    Stroke. 2019 May 14:STROKEAHA118024305. doi: 10.1161/STROKEAHA.118.024305.
    PubMed     Abstract available


  111. SUR NB, Wang K, Di Tullio MR, Gutierrez CM, et al
    Disparities and Temporal Trends in the Use of Anticoagulation in Patients With Ischemic Stroke and Atrial Fibrillation.
    Stroke. 2019 May 14:STROKEAHA118023959. doi: 10.1161/STROKEAHA.118.023959.
    PubMed     Abstract available


  112. LIN MH, Kamel H, Singer DE, Wu YL, et al
    Perioperative/Postoperative Atrial Fibrillation and Risk of Subsequent Stroke and/or Mortality.
    Stroke. 2019 May 2:STROKEAHA118023921. doi: 10.1161/STROKEAHA.118.023921.
    PubMed     Abstract available


  113. YANG XM, Rao ZZ, Gu HQ, Zhao XQ, et al
    Atrial Fibrillation Known Before or Detected After Stroke Share Similar Risk of Ischemic Stroke Recurrence and Death.
    Stroke. 2019;50:1124-1129.
    PubMed     Abstract available


    April 2019
  114. BERMAN JP, Norby FL, Mosley T, Soliman EZ, et al
    Atrial Fibrillation and Brain Magnetic Resonance Imaging Abnormalities.
    Stroke. 2019;50:783-788.
    PubMed     Abstract available


  115. MACHA K, Marsch A, Siedler G, Breuer L, et al
    Cerebral Ischemia in Patients on Direct Oral Anticoagulants.
    Stroke. 2019;50:873-879.
    PubMed     Abstract available


    March 2019
  116. LEE SR, Choi EK, Han KD, Jung JH, et al
    Optimal Rivaroxaban Dose in Asian Patients With Atrial Fibrillation and Normal or Mildly Impaired Renal Function.
    Stroke. 2019 Mar 27:STROKEAHA118024210. doi: 10.1161/STROKEAHA.118.024210.
    PubMed     Abstract available


  117. SHAO IY, Power MC, Mosley T, Jack C Jr, et al
    Association of Atrial Fibrillation With White Matter Disease.
    Stroke. 2019 Mar 18:STROKEAHA118023386. doi: 10.1161/STROKEAHA.118.023386.
    PubMed     Abstract available


  118. NIELSEN PB, Skjoth F, Sogaard M, Kjaeldgaard JN, et al
    Non-Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Atrial Fibrillation Patients With Intracerebral Hemorrhage.
    Stroke. 2019 Mar 14:STROKEAHA118023797. doi: 10.1161/STROKEAHA.118.023797.
    PubMed     Abstract available


    February 2019
  119. DI CASTELNUOVO A, Veronesi G, Costanzo S, Zeller T, et al
    NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide) and the Risk of Stroke.
    Stroke. 2019 Feb 21:STROKEAHA118023218. doi: 10.1161/STROKEAHA.118.023218.
    PubMed     Abstract available


    December 2018
  120. CHO MS, Yun JE, Park JJ, Kim YJ, et al
    Outcomes After Use of Standard- and Low-Dose Non-Vitamin K Oral Anticoagulants in Asian Patients With Atrial Fibrillation.
    Stroke. 2018 Dec 3:STROKEAHA118023093. doi: 10.1161/STROKEAHA.118.023093.
    PubMed     Abstract available


  121. RUIZ VARGAS E, Sposato LA, Lee SAW, Hachinski V, et al
    Anticoagulation Therapy for Atrial Fibrillation in Patients With Alzheimer's Disease.
    Stroke. 2018;49:2844-2850.
    PubMed     Abstract available


  122. LIP GYH, Keshishian A, Li X, Hamilton M, et al
    Effectiveness and Safety of Oral Anticoagulants Among Nonvalvular Atrial Fibrillation Patients.
    Stroke. 2018;49:2933-2944.
    PubMed     Abstract available


  123. SHPAK M, Ramakrishnan A, Nadasdy Z, Cowperthwaite M, et al
    Higher Incidence of Ischemic Stroke in Patients Taking Novel Oral Anticoagulants.
    Stroke. 2018;49:2851-2856.
    PubMed     Abstract available


  124. PERSSON CU, Svardsudd K, Rusek L, Blomstrand C, et al
    Determinants of Stroke in a General Male Population.
    Stroke. 2018;49:2830-2836.
    PubMed     Abstract available


    November 2018
  125. YIIN GSC, Li L, Bejot Y, Rothwell PM, et al
    Time Trends in Atrial Fibrillation-Associated Stroke and Premorbid Anticoagulation.
    Stroke. 2018 Nov 29:STROKEAHA118022249. doi: 10.1161/STROKEAHA.118.022249.
    PubMed     Abstract available


  126. CHEN LY, Norby FL, Chamberlain AM, MacLehose RF, et al
    CHA2DS2-VASc Score and Stroke Prediction in Atrial Fibrillation in Whites, Blacks, and Hispanics.
    Stroke. 2018 Nov 29:STROKEAHA118021453. doi: 10.1161/STROKEAHA.118.021453.
    PubMed     Abstract available


  127. JANION-SADOWSKA A, Chrapek M, Konieczynska M, Undas A, et al
    Altered Fibrin Clot Properties Predict Stroke and Bleedings in Patients With Atrial Fibrillation on Rivaroxaban.
    Stroke. 2018 Nov 21:STROKEAHA118023712. doi: 10.1161/STROKEAHA.118.023712.
    PubMed     Abstract available


  128. MURPHY MP, Kuramatsu JB, Leasure A, Falcone GJ, et al
    Cardioembolic Stroke Risk and Recovery After Anticoagulation-Related Intracerebral Hemorrhage.
    Stroke. 2018;49:2652-2658.
    PubMed     Abstract available


  129. YAGHI S, Chang AD, Cutting S, Jayaraman M, et al
    Troponin Improves the Yield of Transthoracic Echocardiography in Ischemic Stroke Patients of Determined Stroke Subtype.
    Stroke. 2018;49:2777-2779.
    PubMed     Abstract available


    October 2018
  130. WITSCH J, Merkler AE, Chen ML, Navi BB, et al
    Incidence of Atrial Fibrillation in Patients With Recent Ischemic Stroke Versus Matched Controls.
    Stroke. 2018;49:2529-2531.
    PubMed     Abstract available


  131. OGAWA H, An Y, Ikeda S, Aono Y, et al
    Progression From Paroxysmal to Sustained Atrial Fibrillation Is Associated With Increased Adverse Events.
    Stroke. 2018;49:2301-2308.
    PubMed     Abstract available


  132. YU HT, Yang PS, Kim TH, Jang E, et al
    Impact of Renal Function on Outcomes With Edoxaban in Real-World Patients With Atrial Fibrillation.
    Stroke. 2018;49:2421-2429.
    PubMed     Abstract available


  133. CHAUSSON N, Soumah D, Aghasaryan M, Altarcha T, et al
    Reversal of Vitamin K Antagonist Therapy Before Thrombolysis for Acute Ischemic Stroke.
    Stroke. 2018;49:2526-2528.
    PubMed     Abstract available


    September 2018
  134. FORSLUND T, Komen JJ, Andersen M, Wettermark B, et al
    Improved Stroke Prevention in Atrial Fibrillation After the Introduction of Non-Vitamin K Antagonist Oral Anticoagulants.
    Stroke. 2018;49:2122-2128.
    PubMed     Abstract available


    July 2018
  135. KIM TH, Yang PS, Yu HT, Jang E, et al
    Age Threshold for Ischemic Stroke Risk in Atrial Fibrillation: Cohort Data Covering the Entire Korean Population.
    Stroke. 2018 Jul 16. pii: STROKEAHA.118.021047.
    PubMed     Abstract available


  136. FROST L, Johnsen SP
    Age and Risk of Stroke in Asians With Atrial Fibrillation: The Clock Is Ticking.
    Stroke. 2018 Jul 16. pii: STROKEAHA.118.022038.
    PubMed    


  137. LAMSAM L, Sussman ES, Iyer AK, Bhambhvani HP, et al
    Intracranial Hemorrhage in Deep Vein Thrombosis/Pulmonary Embolus Patients Without Atrial Fibrillation: Direct Oral Anticoagulants Versus Warfarin.
    Stroke. 2018 Jul 10. pii: STROKEAHA.118.022156.
    PubMed     Abstract available


    June 2018
  138. HAMATANI Y, Nagai T, Nakai M, Nishimura K, et al
    Elevated Plasma D-Dimer Level Is Associated With Short-Term Risk of Ischemic Stroke in Patients With Acute Heart Failure.
    Stroke. 2018 Jun 7. pii: STROKEAHA.118.021899. doi: 10.1161/STROKEAHA.118.021899
    PubMed     Abstract available


    May 2018
  139. GUROL ME
    Secondary Stroke Prevention in Atrial Fibrillation: New Insights Into an Old Problem.
    Stroke. 2018 May 8. pii: STROKEAHA.118.021262. doi: 10.1161/STROKEAHA.118.021262
    PubMed    


  140. REDDY VY, Akehurst RL, Amorosi SL, Gavaghan MB, et al
    Cost-Effectiveness of Left Atrial Appendage Closure With the WATCHMAN Device Compared With Warfarin or Non-Vitamin K Antagonist Oral Anticoagulants for Secondary Prevention in Nonvalvular Atrial Fibrillation.
    Stroke. 2018 May 8. pii: STROKEAHA.117.018825. doi: 10.1161/STROKEAHA.117.018825
    PubMed     Abstract available


    April 2018
  141. KURMANN R, Engelter ST, Michel P, Luft AR, et al
    Impact of Smoking on Clinical Outcome and Recanalization After Intravenous Thrombolysis for Stroke: Multicenter Cohort Study.
    Stroke. 2018 Apr 10. pii: STROKEAHA.117.017976.
    PubMed     Abstract available


    March 2018
  142. KAMEL H, Bartz TM, Elkind MSV, Okin PM, et al
    Atrial Cardiopathy and the Risk of Ischemic Stroke in the CHS (Cardiovascular Health Study).
    Stroke. 2018 Mar 13. pii: STROKEAHA.117.020059.
    PubMed     Abstract available


  143. YOUSUFUDDIN M, Young N, Keenan L, Olson T, et al
    Five-Year Mortality After Transient Ischemic Attack: Focus on Cardiometabolic Comorbidity and Hospital Readmission.
    Stroke. 2018;49:730-733.
    PubMed     Abstract available


    January 2018
  144. LINDLEY RI
    Stroke Prevention in the Very Elderly.
    Stroke. 2018 Jan 25. pii: STROKEAHA.117.017952.
    PubMed    


  145. FISHER M, Hill JA
    Ischemic Stroke Mandates Cross-Disciplinary Collaboration.
    Stroke. 2018 Jan 8. pii: STROKEAHA.117.020014. doi: 10.1161/STROKEAHA.117.020014
    PubMed    


    December 2017
  146. GUROL ME
    Nonpharmacological Management of Atrial Fibrillation in Patients at High Intracranial Hemorrhage Risk.
    Stroke. 2017 Dec 4. pii: STROKEAHA.117.017081. doi: 10.1161/STROKEAHA.117.017081
    PubMed    



  147. Correction to: Stratifying Stroke Risk in Atrial Fibrillation: Beyond Clinical Risk Scores.
    Stroke. 2017;48:e368.
    PubMed    


    November 2017
  148. PROIETTI M, Romanazzi I, Romiti GF, Farcomeni A, et al
    Real-World Use of Apixaban for Stroke Prevention in Atrial Fibrillation: A Systematic Review and Meta-Analysis.
    Stroke. 2017 Nov 22. pii: STROKEAHA.117.018395.
    PubMed     Abstract available


  149. YAMADA S, Lin CY, Chang SL, Chao TF, et al
    Risk of Stroke in Patients With Short-Run Atrial Tachyarrhythmia.
    Stroke. 2017 Nov 16. pii: STROKEAHA.117.018475.
    PubMed     Abstract available


  150. ETHERTON MR, Wu O, Cougo P, Giese AK, et al
    Structural Integrity of Normal Appearing White Matter and Sex-Specific Outcomes After Acute Ischemic Stroke.
    Stroke. 2017 Nov 10. pii: STROKEAHA.117.019258.
    PubMed     Abstract available


  151. SHOAMANESH A, Charidimou A, Sharma M, Hart RG, et al
    Should Patients With Ischemic Stroke or Transient Ischemic Attack With Atrial Fibrillation and Microbleeds be Anticoagulated?
    Stroke. 2017 Nov 7. pii: STROKEAHA.117.018467. doi: 10.1161/STROKEAHA.117.018467
    PubMed    


    October 2017
  152. VINEREANU D, Lopes RD, Mulder H, Gersh BJ, et al
    Echocardiographic Risk Factors for Stroke and Outcomes in Patients With Atrial Fibrillation Anticoagulated With Apixaban or Warfarin.
    Stroke. 2017 Oct 31. pii: STROKEAHA.117.017574.
    PubMed     Abstract available


  153. CHATURVEDI S, Molina CA, Selim MH, Diener HC, et al
    Off-Label Use of Direct Oral Anticoagulants in Intracerebral Hemorrhage Patients With Prosthetic Valves.
    Stroke. 2017 Oct 13. pii: STROKEAHA.117.017592.
    PubMed    


  154. CHA MJ, Choi EK, Han KD, Lee SR, et al
    Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Asian Patients With Atrial Fibrillation.
    Stroke. 2017 Oct 3. pii: STROKEAHA.117.018773. doi: 10.1161/STROKEAHA.117.018773
    PubMed     Abstract available


    September 2017
  155. KIM TH, Yang PS, Kim D, Yu HT, et al
    CHA2DS2-VASc Score for Identifying Truly Low-Risk Atrial Fibrillation for Stroke: A Korean Nationwide Cohort Study.
    Stroke. 2017 Sep 22. pii: STROKEAHA.117.018551.
    PubMed     Abstract available


  156. HILKENS NA, Algra A, Greving JP
    Predicting Major Bleeding in Ischemic Stroke Patients With Atrial Fibrillation.
    Stroke. 2017 Sep 20. pii: STROKEAHA.117.019183.
    PubMed     Abstract available


  157. SELIM M, Diener HC
    Atrial Fibrillation and Microbleeds.
    Stroke. 2017 Sep 15. pii: STROKEAHA.117.017085.
    PubMed    


  158. GOLDSTEIN LB
    Anticoagulation in Patients With Atrial Fibrillation in the Setting of Prior Hemorrhage: An Ongoing Dilemma.
    Stroke. 2017 Sep 15. pii: STROKEAHA.117.017082.
    PubMed    


  159. THIJS V
    Atrial Fibrillation Detection: Fishing for An Irregular Heartbeat Before and After Stroke.
    Stroke. 2017 Sep 15. pii: STROKEAHA.117.017083.
    PubMed    


  160. YAGHI S, Kamel H
    Stratifying Stroke Risk in Atrial Fibrillation: Beyond Clinical Risk Scores.
    Stroke. 2017 Sep 15. pii: STROKEAHA.117.017084.
    PubMed    


  161. FISHER M
    Introducing Focused Updates in Cerebrovascular Disease.
    Stroke. 2017 Sep 15. pii: STROKEAHA.117.019122.
    PubMed    


  162. DRABIK L, Wolkow P, Undas A
    Fibrin Clot Permeability as a Predictor of Stroke and Bleeding in Anticoagulated Patients With Atrial Fibrillation.
    Stroke. 2017 Sep 13. pii: STROKEAHA.117.018143.
    PubMed     Abstract available


  163. BISSON A, Clementy N, Bodin A, Angoulvant D, et al
    Relationship of Preexisting Cardiovascular Comorbidities to Newly Diagnosed Atrial Fibrillation After Ischemic Stroke.
    Stroke. 2017 Sep 1. pii: STROKEAHA.117.018251. doi: 10.1161/STROKEAHA.117.018251
    PubMed     Abstract available


    August 2017
  164. YOON CY, Noh J, Jhee JH, Chang TI, et al
    Warfarin Use in Patients With Atrial Fibrillation Undergoing Hemodialysis: A Nationwide Population-Based Study.
    Stroke. 2017 Aug 11. pii: STROKEAHA.117.017114.
    PubMed     Abstract available


  165. THOREN M, Azevedo E, Dawson J, Egido JA, et al
    Predictors for Cerebral Edema in Acute Ischemic Stroke Treated With Intravenous Thrombolysis.
    Stroke. 2017 Aug 3. pii: STROKEAHA.117.018223. doi: 10.1161/STROKEAHA.117.018223
    PubMed     Abstract available



  166. Correction to: Ischemic Stroke in Nonvalvular Atrial Fibrillation at Warfarin Initiation: Assessment via a Large Insurance Database.
    Stroke. 2017;48:e239.
    PubMed    


    July 2017
  167. NTAIOS G, Papavasileiou V, Makaritsis K, Vemmos K, et al
    Real-World Setting Comparison of Nonvitamin-K Antagonist Oral Anticoagulants Versus Vitamin-K Antagonists for Stroke Prevention in Atrial Fibrillation: A Systematic Review and Meta-Analysis.
    Stroke. 2017 Jul 17. pii: STROKEAHA.117.017549.
    PubMed     Abstract available


  168. MAZUREK M, Shantsila E, Lane DA, Wolff A, et al
    Secondary Versus Primary Stroke Prevention in Atrial Fibrillation: Insights From the Darlington Atrial Fibrillation Registry.
    Stroke. 2017 Jul 5. pii: STROKEAHA.116.016146. doi: 10.1161/STROKEAHA.116.016146
    PubMed     Abstract available


    June 2017
  169. HERNANDEZ I, Saba S, Zhang Y
    Geographic Variation in the Use of Oral Anticoagulation Therapy in Stroke Prevention in Atrial Fibrillation.
    Stroke. 2017 Jun 27. pii: STROKEAHA.117.017683.
    PubMed     Abstract available


  170. COLEMAN CI, Peacock WF, Bunz TJ, Alberts MJ, et al
    Effectiveness and Safety of Apixaban, Dabigatran, and Rivaroxaban Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation and Previous Stroke or Transient Ischemic Attack.
    Stroke. 2017 Jun 27. pii: STROKEAHA.117.017474.
    PubMed     Abstract available


  171. GOUNIS MJ, Chapot R
    Histological Composition and the Origin of the Thrombus: A New Diagnostic Assay for Secondary Stroke Prevention?
    Stroke. 2017 Jun 16. pii: STROKEAHA.117.017630.
    PubMed    


  172. FLINT AC, Conell C, Ren X, Kamel H, et al
    Statin Adherence Is Associated With Reduced Recurrent Stroke Risk in Patients With or Without Atrial Fibrillation.
    Stroke. 2017 Jun 8. pii: STROKEAHA.117.017343. doi: 10.1161/STROKEAHA.117.017343
    PubMed     Abstract available


    May 2017
  173. APPELROS P, Farahmand B, Terent A, Asberg S, et al
    To Treat or Not to Treat: Anticoagulants as Secondary Preventives to the Oldest Old With Atrial Fibrillation.
    Stroke. 2017 May 9. pii: STROKEAHA.117.016902. doi: 10.1161/STROKEAHA.117.016902
    PubMed     Abstract available


  174. LUBITZ SA, Parsons OE, Anderson CD, Benjamin EJ, et al
    Atrial Fibrillation Genetic Risk and Ischemic Stroke Mechanisms.
    Stroke. 2017 May 3. pii: STROKEAHA.116.016198. doi: 10.1161/STROKEAHA.116.016198
    PubMed     Abstract available


    April 2017
  175. KIM TH, Yang PS, Uhm JS, Kim JY, et al
    CHA2DS2-VASc Score (Congestive Heart Failure, Hypertension, Age >/=75 [Doubled], Diabetes Mellitus, Prior Stroke or Transient Ischemic Attack [Doubled], Vascular Disease, Age 65-74, Female) for Stroke in Asian Patients With Atrial Fibrillation: A K
    Stroke. 2017 Apr 28. pii: STROKEAHA.117.016926.
    PubMed     Abstract available


  176. MACHADO-ALBA JE, Arias-Jaramillo DR, Gaviria-Mendoza A
    Letter by Machado-Alba et al Regarding Article, "Rivaroxaban Versus Dabigatran or Warfarin in Real-World Studies of Stroke Prevention in Atrial Fibrillation: Systematic Review and Meta-Analysis".
    Stroke. 2017 Apr 28. pii: STROKEAHA.117.017375.
    PubMed    


  177. BAI Y, Shantsila A, Lip GYH
    Response by Bai et al to Letter Regarding Article, "Rivaroxaban Versus Dabigatran or Warfarin in Real-World Studies of Stroke Prevention in Atrial Fibrillation: Systematic Review and Meta-Analysis".
    Stroke. 2017 Apr 28. pii: STROKEAHA.117.017460.
    PubMed    


  178. TEPPER PG, Liu X, Hamilton M, Mardekian J, et al
    Ischemic Stroke in Nonvalvular Atrial Fibrillation at Warfarin Initiation: Assessment via a Large Insurance Database.
    Stroke. 2017 Apr 26. pii: STROKEAHA.116.015535.
    PubMed     Abstract available


  179. LUBITZ SA, Seshadri S, Benjamin EJ
    Response by Lubitz et al to Letter Regarding Article, "Stroke as the Initial Manifestation of Atrial Fibrillation: The Framingham Heart Study".
    Stroke. 2017 Apr 17. pii: STROKEAHA.117.017108.
    PubMed    


  180. SPOSATO LA, Fridman S, Saposnik G
    Letter by Sposato et al Regarding Article, "Stroke as the Initial Manifestation of Atrial Fibrillation: The Framingham Heart Study".
    Stroke. 2017 Apr 17. pii: STROKEAHA.117.017066.
    PubMed    


  181. COLL-VINENT B, Martin A, Sanchez J, Tamargo J, et al
    Benefits of Emergency Departments' Contribution to Stroke Prophylaxis in Atrial Fibrillation: The EMERG-AF Study (Emergency Department Stroke Prophylaxis and Guidelines Implementation in Atrial Fibrillation).
    Stroke. 2017 Apr 7. pii: STROKEAHA.116.014855. doi: 10.1161/STROKEAHA.116.014855
    PubMed     Abstract available


    February 2017
  182. MATTSSON N, Kumarathurai P, Larsen BS, Nielsen OW, et al
    Mild Hypokalemia and Supraventricular Ectopy Increases the Risk of Stroke in Community-Dwelling Subjects.
    Stroke. 2017 Feb 7. pii: STROKEAHA.116.015439. doi: 10.1161/STROKEAHA.116.015439
    PubMed     Abstract available


    January 2017
  183. HOLT TA, Dalton A, Marshall T, Fay M, et al
    Automated Software System to Promote Anticoagulation and Reduce Stroke Risk: Cluster-Randomized Controlled Trial.
    Stroke. 2017 Jan 24. pii: STROKEAHA.116.015468.
    PubMed     Abstract available


    October 2016
  184. WOOD AD, Mannu GS, Clark AB, Tiamkao S, et al
    Rheumatic Mitral Valve Disease Is Associated With Worse Outcomes in Stroke: A Thailand National Database Study.
    Stroke. 2016 Oct 4. pii: STROKEAHA.116.014512.
    PubMed     Abstract available


    July 2016
  185. YONG JH, Thavorn K, Hoch JS, Mamdani M, et al
    Potential Cost-Effectiveness of Ambulatory Cardiac Rhythm Monitoring After Cryptogenic Stroke.
    Stroke. 2016 Jul 28. pii: STROKEAHA.115.011979.
    PubMed     Abstract available


    June 2016
  186. WINTERHOLLER M, Hollander C, Kerling F, Weber I, et al
    Stroke in Duchenne Muscular Dystrophy: A Retrospective Longitudinal Study in 54 Patients.
    Stroke. 2016 Jun 28. pii: STROKEAHA.116.013678.
    PubMed     Abstract available


  187. STANNE TM, Aberg ND, Nilsson S, Jood K, et al
    Low Circulating Acute Brain-Derived Neurotrophic Factor Levels Are Associated With Poor Long-Term Functional Outcome After Ischemic Stroke.
    Stroke. 2016 Jun 14. pii: STROKEAHA.115.012383.
    PubMed     Abstract available


  188. BERROUSCHOT J, Stoll A, Hogh T, Eschenfelder CC, et al
    Intravenous Thrombolysis With Recombinant Tissue-Type Plasminogen Activator in a Stroke Patient Receiving Dabigatran Anticoagulant After Antagonization With Idarucizumab.
    Stroke. 2016 Jun 14. pii: STROKEAHA.116.013550.
    PubMed     Abstract available


  189. PANDEY A, Patel MR, Willis B, Gao A, et al
    Association Between Midlife Cardiorespiratory Fitness and Risk of Stroke: The Cooper Center Longitudinal Study.
    Stroke. 2016 Jun 9. pii: STROKEAHA.115.011532.
    PubMed     Abstract available


    May 2016
  190. GIOIA LC, Kate M, Sivakumar L, Hussain D, et al
    Early Rivaroxaban Use After Cardioembolic Stroke May Not Result in Hemorrhagic Transformation: A Prospective Magnetic Resonance Imaging Study.
    Stroke. 2016 May 24. pii: STROKEAHA.116.013491.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Arrhythmias is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: